Drug Shortage Report for SENSIPAR
| Report ID | 230105 |
| Drug Identification Number | 02257149 |
| Brand name | SENSIPAR |
| Common or Proper name | cinacalcet hydrochloride |
| Company Name | AMGEN CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CINACALCET |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Bottles of 30 tablets |
| ATC code | H05BX |
| ATC description | ANTI-PARATHYROID HORMONES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-06-10 |
| Estimated end date | |
| Actual end date | 2024-09-16 |
| Shortage status | Resolved |
| Updated date | 2024-09-18 |
| Company comments | Discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6775 FINANCIAL DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0A4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-09-18 | English | Compare |
| v2 | 2024-06-11 | French | Compare |
| v1 | 2024-06-11 | English | Compare |
Showing 1 to 3 of 3